JOA - 2026-11-01 - Journal Article
Primary Cemented Total Knee Arthroplasty With Fully Cemented Short-Stemmed Tibial Components Is Not Associated With Reduced Five-Year Survival.
Walsh ZA, Call CM, Mackenzie JA, Shevenell BE, Noyes ML, McGrory BJ, Rana AJ
Topics
Key Takeaway
Fully cemented short tibial stem extensions in primary TKA did not reduce all-cause revision risk (HR 0.56, 95% CI 0.06–2.20) compared to standard stemless tibial components at mean 5.8-year follow-up.
Summary Depth
Choose how much analysis to show on this article page.
Summary
This study evaluated whether fully cemented short tibial stem extensions reduce revision risk in primary TKA by comparing stemmed (n=173) versus nonstemmed (n=3,757) tibial components using Cox proportional hazards modeling. All-cause revision occurred in 0.98% of NST and 0.58% of ST patients, with aseptic loosening occurring in only 2 patients (both NST, 0.05%). Tibial stem extension was not a significant predictor of revision (HR 0.56, 95% CI 0.06–2.20), while morbid obesity (HR 4.04), male sex (HR 2.05), and younger age (HR 0.96 per year) were.
Key Limitation
The stemmed cohort (n=173) is underpowered to detect a meaningful difference in a low-frequency outcome (aseptic loosening rate 0.05%), and non-random allocation of stem extensions to presumably higher-risk patients introduces confounding that Cox modeling cannot fully correct.
Original Abstract
BACKGROUND
Emerging evidence suggests revision for early aseptic loosening following total knee arthroplasty (TKA) is associated with both short, native tibial stem (TS) design and morbid obesity (body mass index ≥ 40). The use of short, fully cemented stem extensions has been suggested to mitigate this risk.
METHODS
A retrospective review was performed of patients undergoing primary TKA at a single, large academic center between August 2015 and December 2022. Cohorts were created based on the presence (stemmed tibia (ST)) or absence (nonstemmed tibia (NST)) of a fully cemented short TS extension. Cox proportional hazards models were used to assess implant survival across all follow-up periods. A total of 3,930 patients were included (NST = 3,757, ST = 173). The mean time to final follow-up was 5.8 years for the NST cohort and 4.6 years for the ST cohort (P < 0.001).
RESULTS
All-cause revision occurred in 0.98% (n = 37) of the NST cohort at a mean time of 25 months. There was one revision (0.58%) in the ST cohort. Aseptic loosening occurred in two patients (0.05%), both in the NST cohort, at an average of 65 months. Morbid obesity (hazard ratio (HR) = 4.04, 95% confidence interval (CI): 1.75 to 8.60), age (HR = 0.96, 95% CI: 0.92 to 0.99), and being a man (HR = 2.05, 95% CI: 1.08 to 3.97) were significant predictors of all-cause revision, while TS extension (HR = 0.56, 95% CI: 0.06 to 2.20) was not.
CONCLUSIONS
This study did not find short, native TS design to be associated with early tibial aseptic loosening nor increased all-cause revision following primary TKA. Morbid obesity, younger age, and being a man were associated with greater risk of revision, regardless of stem extension at five years.